Defective Breast Mesh, Acellular Dermal Matrix (ADM), and Bioabsorbable Scaffold Injury Attorneys in City of DeSoto: The Complete Guide for Women, Families, and Survivors
For women in City of DeSoto who have undergone breast reconstruction, revision, or cosmetic augmentation, the expectation is always one of healing, restoration, and renewed confidence. Whether you are a breast cancer survivor who chose reconstruction following a mastectomy or an aesthetic patient seeking a mastopexy, or “internal bra” procedure, you placed your trust in the medical devices implanted in your body. We understand that discovering those devices—surgical mesh, acellular dermal matrix (ADM), or bioabsorbable scaffolds—may be defective is more than a medical complication; it is a profound betrayal of that trust.
At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we have spent twenty-seven years advocating for the catastrophically injured. Our managing partner, Ralph Manginello, has been licensed by the State Bar of Texas since 1998 and is admitted to the United States District Court for the Southern District of Texas, providing a backbone of federal litigation experience that is critical when facing global medical device manufacturers. We recognize that for residents of City of DeSoto, navigating the complex medical landscape of Dallas County and the North Texas region is exhausting enough without the added burden of a device-related injury. We are here to provide the technical authority, legal rigor, and compassionate advocacy you deserve.
If you are experiencing unexplained redness, swelling, chronic pain, or have been diagnosed with a rare malignancy like BIA-ALCL or BIA-SCC, you are not alone. Our team, including associate attorney Lupe Peña, who provides full consultations in fluent Spanish, is dedicated to helping City of DeSoto families secure justice against the corporations that prioritized profits over patient safety.
Understanding the Devices: Mesh, ADM, and Bioabsorbable Scaffolds
Many patients in City of DeSoto are surprised to learn that the products used to support their implants or tissue expanders were often used “off-label,” meaning the FDA never specifically cleared them for use in breast surgery. To understand your legal options, we must first define the three primary categories of devices implicated in this litigation.
Acellular Dermal Matrix (ADM)
ADM is a biologic material derived from human cadaver skin or animal tissue (porcine or bovine). Manufacturers process this tissue to remove cells while leaving a regenerative “scaffold” intended to encourage your own body’s tissue ingrowth. In City of DeSoto surgical centers, ADM is frequently used to create a pocket for a breast implant, particularly in “pre-pectoral” reconstruction where the implant sits on top of the chest muscle. Common brands include AlloDerm (Allergan/AbbVie), Strattice, FlexHD, and AlloMax.
Bioabsorbable Scaffolds
Unlike permanent synthetic mesh, bioabsorbable scaffolds are designed to provide temporary support and then resorb into the body over 12 to 24 months. These are often marketed for “internal bra” procedures to prevent implant “bottoming out” or to support a breast lift. The most prominent material used here is poly-4-hydroxybutyrate (P4HB). The brand universe for these scaffolds includes GalaFLEX and Phasix, both manufactured by subsidiaries of Becton Dickinson (BD).
Synthetic Surgical Mesh
While less common in modern breast surgery, some surgeons have used traditional polypropylene mesh (the same material used in hernia repairs) to support breast tissue. These permanent synthetics have high rates of erosion and chronic inflammation, leading to significant complications for patients.
The FDA Regulatory Mirror: 510(k) and the Regulatory Failure
A central pillar of our litigation strategy for City of DeSoto clients involves the FDA’s 510(k) clearance pathway. It is vital to understand that “FDA Cleared” is not the same as “FDA Approved.” Most of the mesh and ADM products used in breast surgery reached the market through the 510(k) pathway, which only requires the manufacturer to show their device is “substantially equivalent” to a “predicate” device already on the market.
As the U.S. Supreme Court noted in Medtronic v. Lohr, 510(k) is a comparative shortcut, not an evaluative determination of safety and effectiveness. This has led to “predicate creep,” where a device like GalaFLEX—intended for breast surgery—cites a surgical suture as its predicate.
On November 9, 2023, the FDA issued a critical letter to health care providers that resonates deeply with our cases in City of DeSoto. The FDA stated verbatim: “The safety and effectiveness of surgical mesh in breast surgery, including in augmentation or reconstruction, has not been determined by the FDA.” This admission by the federal regulator is a powerful piece of evidence in our fight to show that manufacturers failed to warn City of DeSoto patients and their surgeons about the unproven nature of these devices.
The Spectrum of Complications for City of DeSoto Patients
The injuries caused by defective mesh and ADM are not just aesthetic; they are often systemic and life-altering. We represent women from across City of DeSoto and Dallas County who are suffering from the following:
Red Breast Syndrome (RBS)
This is a noninfectious, sterile inflammatory reaction specific to ADM products. Our research and the medical literature suggest RBS is often mediated by endotoxins—bacterial remnants—that survive the sterilization process. Patients experience a localized, bright red rash over the reconstruction area. We have seen that exchanging the ADM brand often resolves the issue, proving that the device itself was the catalyst.
BIA-ALCL (Breast Implant-Associated Anaplastic Large Cell Lymphoma)
This is a CD30-positive, ALK-negative T-cell lymphoma that develops in the scar capsule around textured implants. While Allergan’s BIOCELL textured implants were recalled in July 2019 due to this risk, many women in City of DeSoto were never notified. Symptoms often include a “late seroma”—a sudden fluid collection developing 7 to 10 years after surgery.
BIA-SCC (Breast Implant-Associated Squamous Cell Carcinoma)
This is an emerging and aggressive epithelial tumor found in the implant capsule. The FDA issued an updated safety communication in March 2023 regarding BIA-SCC, which has a latency of up to 42 years. For City of DeSoto women who had surgery decades ago, this remains a hidden threat.
Mechanical Failures and Reconstruction Loss
We see cases of scaffold extrusion, where the mesh or ADM erodes through the skin, and reconstruction failure, where chronic infection leads to the permanent loss of the breast reconstruction. This often leaves “flat closure” as the only remaining option, a devastating outcome for breast cancer survivors.
The Whistleblower Record: Becton Dickinson and GalaFLEX
Our firm pays close attention to the investigative record, including the testimony of Dr. Hooman Noorchashm. Dr. Noorchashm, a cardiothoracic surgeon and former Medical Director at Becton Dickinson (BD), was terminated in 2022 after raising internal alarms about the safety of GalaFLEX.
His allegations include that BD withheld data on breast cancer recurrences in GalaFLEX clinical trials from the FDA and engaged in aggressive off-label promotion. For a resident of City of DeSoto who received a GalaFLEX scaffold during a “breast lift” or reconstruction, this whistleblower record provides the “insider” evidence necessary to challenge corporate narratives in court. We bring this level of investigative depth to every case, ensuring that City of DeSoto families are not just filing a claim, but launching a rigorous legal pursuit of the truth.
Legal Advocacy in City of DeSoto and the Northern District of Texas
Filing a lawsuit in City of DeSoto requires a deep understanding of the Texas product liability framework. Under the Texas Civil Practice and Remedies Code, we must navigate specific statutes of limitations and the 15-year statute of repose. Typically, an injured person has two years from the date they discovered—or reasonably should have discovered—the link between their injury and the device to file a suit.
For many women in City of DeSoto, the “discovery” may have occurred as recently as the November 2023 FDA letter. We handle the jurisdictional complexities of filing in the United States District Court for the Northern District of Texas, Dallas Division, or coordinating with national Multidistrict Litigation (MDL), such as Allergan BIOCELL MDL 2921, which is currently being overseen by Judge Brian R. Martinotti in New Jersey. With a bellwether trial in that MDL set for October 19, 2026, the timeline for City of DeSoto survivors to join the litigation is critical.
Our firm is uniquely positioned to handle these high-stakes institutional liability cases. We are currently lead counsel in Bermudez v. Pi Kappa Phi, a $10 million lawsuit against thirteen defendants, which highlights our ability to manage complex, multi-party litigation that results in institutional change. This is the same level of pressure we apply to medical device manufacturers.
Why City of DeSoto Families Choose Attorney911
We are not a generalist personal injury firm. We are a boutique litigation powerhouse that understands the science of mesh biology and the doctrine of federal preemption.
- Federal Court Fluency: Ralph Manginello’s admission to the Southern District of Texas and our experience in the Northern District ensure your case is handled by those comfortable in federal courtrooms where these cases are often moved.
- Bilingual Capability: Associate Lupe Peña conducts consultations in Spanish. In a diverse community like City of DeSoto, we ensure that language is never a barrier to justice.
- No Upfront Costs: We operate on a contingency fee basis. We advance all costs for pathology reviews, expert testimony, and medical record retrieval. We do not get paid unless we recover for you.
- Specialized Medical Knowledge: We understand CD30 immunohistochemistry, P4HB hydrolysis, and the Perez v. Wyeth exception to the learned intermediary doctrine. We know how to prove that the manufacturer’s marketing compromised your surgeon’s judgment.
Frequently Asked Questions for City of DeSoto Residents
Is surgical mesh approved by the FDA for breast surgery?
No. As the FDA stated in late 2023, no surgical mesh product—including ADM and bioabsorbable scaffolds—has been cleared or approved specifically for use in breast reconstruction or augmentation. They are used “off-label,” often based on marketing rather than clinical trials.
What is the statute of limitations in City of DeSoto?
In Texas, you generally have two years from the discovery of your injury to file a lawsuit. However, because these injuries often take years to manifest, the “discovery rule” is vital. We can help you determine the specific deadline based on the date you first connected your symptoms to the mesh or ADM.
Can I sue the manufacturer if my mesh was bioabsorbable?
Yes. Products like GalaFLEX and Phasix are bioabsorbable, but if they fail to absorb on the labeled timeline or cause an inflammatory reaction before they degrade, the manufacturer can be held liable for design defects or failure to warn.
How do I find out which brand of mesh was used in my surgery?
You have a legal right to your medical records. We assist City of DeSoto clients in obtaining full operative reports and implant logs, which contain the Unique Device Identifier (UDI) stickers and lot numbers for the products used in your body.
Who is the lawsuit filed against?
In most cases, the primary defendant is the device manufacturer (e.g., Allergan, BD, MTF Biologics). However, if a hospital in the City of DeSoto area used a product they knew to be defective, or if a surgeon failed to provide adequate informed consent regarding off-label use, other parties may be included in the litigation.
What if I cannot afford to pay for a lawyer?
Our firm works on a contingency fee basis. This means we cover all the costs of the litigation, and you never pay an hourly rate. We only receive a portion of the settlement or verdict if we are successful in recovering compensation for you.
Your Path Forward: Building Your Case in City of DeSoto
If you believe a defective acellular dermal matrix or bioabsorbable scaffold has caused you harm, the steps you take now are vital. We recommend that City of DeSoto patients do the following:
- Request Your Records: Secure the operative report from your mastectomy or reconstruction.
- Preserve Evidence: If you are undergoing a revision surgery, have your surgeon preserve the explanted mesh or tissue for pathology. We can provide a preservation order to the hospital.
- Document Symptoms: Take photographs of any visible redness or swelling and keep a journal of your pain levels.
- Consult Experienced Counsel: Speak with a firm that understands the Northern District of Texas federal venue.
We invite you to contact us at 1-888-ATTY-911 (1-888-288-9911) for a free, confidential consultation. Our managing partner, Ralph Manginello, and our dedicated team are ready to hear your story. Whether you are at a Dallas County hospital or recovering at home in City of DeSoto, we are available to discuss your rights without any obligation.
The road to recovery is long, but it does not have to be traveled alone. We honor the resilience of breast cancer survivors and the strength of every woman navigating these complications. Let us handle the legal fight so you can focus on your health.
Attorney911 | The Manginello Law Firm, PLLC
Principal Office: 1177 West Loop South, Suite 1600, Houston, TX 77027
Serving City of DeSoto, Austin, and Beaumont.
1-888-ATTY-911
Hablamos Español. Lupe Peña conducts full Spanish consultations.
Results disclaimer: Past results, including those in the Bermudez case or our multi-million dollar logging injury settlements, do not guarantee future outcomes. This content is for educational purposes and does not constitute legal advice.
Learn more about Ralph Manginello
Meet Associate Lupe Peña
Contact our firm today
